These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18847512)

  • 21. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.
    Schulman BA; Lindstrom DL; Harlow E
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10453-8. PubMed ID: 9724724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells.
    Merrick KA; Larochelle S; Zhang C; Allen JJ; Shokat KM; Fisher RP
    Mol Cell; 2008 Dec; 32(5):662-72. PubMed ID: 19061641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel landscape of nuclear human CDK2 substrates revealed by in situ phosphorylation.
    Chi Y; Carter JH; Swanger J; Mazin AV; Moritz RL; Clurman BE
    Sci Adv; 2020 Apr; 6(16):eaaz9899. PubMed ID: 32494624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.
    Pandithage R; Lilischkis R; Harting K; Wolf A; Jedamzik B; Lüscher-Firzlaff J; Vervoorts J; Lasonder E; Kremmer E; Knöll B; Lüscher B
    J Cell Biol; 2008 Mar; 180(5):915-29. PubMed ID: 18332217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.
    Adams PD; Sellers WR; Sharma SK; Wu AD; Nalin CM; Kaelin WG
    Mol Cell Biol; 1996 Dec; 16(12):6623-33. PubMed ID: 8943316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.
    Jahn SC; Law ME; Corsino PE; Rowe TC; Davis BJ; Law BK
    Biochemistry; 2013 May; 52(20):3489-501. PubMed ID: 23627734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27.
    Cheng CW; Leong KW; Ng YM; Kwong YL; Tse E
    J Biol Chem; 2017 Dec; 292(52):21431-21441. PubMed ID: 29118189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression.
    Sørensen CS; Lukas C; Kramer ER; Peters JM; Bartek J; Lukas J
    Mol Cell Biol; 2001 Jun; 21(11):3692-703. PubMed ID: 11340163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53.
    Linzen U; Lilischkis R; Pandithage R; Schilling B; Ullius A; Lüscher-Firzlaff J; Kremmer E; Lüscher B; Vervoorts J
    PLoS One; 2015; 10(4):e0123736. PubMed ID: 25860957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Thr160 phosphorylation of Cdk2 in substrate recognition.
    Holmes JK; Solomon MJ
    Eur J Biochem; 2001 Sep; 268(17):4647-52. PubMed ID: 11532001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Hepatitis B Virus Replication by Cyclin Docking Motifs in Core Protein.
    Liu H; Xi J; Hu J
    J Virol; 2021 May; 95(12):. PubMed ID: 33789995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a potential allosteric ligand binding site in CDK2.
    Betzi S; Alam R; Martin M; Lubbers DJ; Han H; Jakkaraj SR; Georg GI; Schönbrunn E
    ACS Chem Biol; 2011 May; 6(5):492-501. PubMed ID: 21291269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allostery governs Cdk2 activation and differential recognition of CDK inhibitors.
    Majumdar A; Burban DJ; Muretta JM; Thompson AR; Engel TA; Rasmussen DM; Subrahmanian MV; Veglia G; Thomas DD; Levinson NM
    Nat Chem Biol; 2021 Apr; 17(4):456-464. PubMed ID: 33526892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autocatalytic phosphorylation of CDK2 at the activating Thr160.
    Abbas T; Jha S; Sherman NE; Dutta A
    Cell Cycle; 2007 Apr; 6(7):843-52. PubMed ID: 17361108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex.
    De Vivo M; Cavalli A; Bottegoni G; Carloni P; Recanatini M
    Proteins; 2006 Jan; 62(1):89-98. PubMed ID: 16292742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical genetics reveals a specific requirement for Cdk2 activity in the DNA damage response and identifies Nbs1 as a Cdk2 substrate in human cells.
    Wohlbold L; Merrick KA; De S; Amat R; Kim JH; Larochelle S; Allen JJ; Zhang C; Shokat KM; Petrini JH; Fisher RP
    PLoS Genet; 2012 Aug; 8(8):e1002935. PubMed ID: 22927831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of cell division by intrinsically unstructured proteins: intrinsic flexibility, modularity, and signaling conduits.
    Galea CA; Wang Y; Sivakolundu SG; Kriwacki RW
    Biochemistry; 2008 Jul; 47(29):7598-609. PubMed ID: 18627125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
    Brown NR; Noble ME; Lawrie AM; Morris MC; Tunnah P; Divita G; Johnson LN; Endicott JA
    J Biol Chem; 1999 Mar; 274(13):8746-56. PubMed ID: 10085115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.